Petros Pharmaceuticals(NASDAQ:PTPI) 
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an approved PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializ...
Website: http://www.petrospharma.com
Founded: 2020
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.75
H 1.75
L 1.50
C 1.75
V 2,262,078
10EMA 1.75
20EMA 1.75
60EMA 1.75
120EMA 1.75
250EMA 1.75